In the mouse model, the dose-limiting organ could possibly be the bone marrow.
Using a mouse model, the efficacy of these arteether lipid formulations against Plasmodium berghei was evaluated.
In the syngeneic mouse model, the human tumors (xenobiotic) usually exhibit immunological compatibility with the host mice.
For the mouse model, the S value for 131I was 10% and 60% lower than that for 123I and 125I, respectively.
In a Lkb1-deficient lung cancer mouse model, the quenching of ROS has been validated to functionally inhibit the ADC-to-SCC transdifferentiation (Li et al., 2015b).
For the mouse model, the S value was 280% and 110% higher for 131I than that for 123I and 125I, respectively.
In this A53T α-Syn+/+ mouse model, the transgenic α-Syn expression is controlled by the prion protein promoter [31].
In the De Keersmaecker mouse model, the TLX1 transgene is regulated directly by the proximal Lck promoter.
In this stable mouse model, the inhibitory effect of shRNA523 was examined, and significant reduction in Fluc activity was observed.
In our mouse model, the relative proportion of multiple cytokine production by CD8 cells was much higher in the i.d.
In the hpg mouse model, the sexual modification of the AVPV kisspeptin neuronal population does not occur.
